期刊文献+

慢性乙型病毒性肝炎患者检测肽抗菌药物Cathelicidin hCAP18/LL-37的临床意义 被引量:2

Clinical value of detecting plasma cathelicidin hCAP18/LL-37 in patients with chronic hepatitis B
下载PDF
导出
摘要 目的探讨肽抗菌药物hCAP18/LL-37在慢性乙型病毒性肝炎(乙型肝炎)中的临床意义。方法将90例慢性乙型肝炎患者分成轻、中、重3组,每组30例,用微孔法酶联免疫吸附实验分别检测患者血浆LL-37水平,并与健康对照组(n=30)比较,同时进行组间比较。结果慢性乙型肝炎患者血浆的LL-37水平显著低于健康对照组(P<0.01)。患者血浆中LL-37水平在慢性乙型肝炎轻、中、重组中均值分别是38.93、33.11、12.87ng/mL,随病情加重而逐渐降低,组间比较差异有统计学意义(P<0.01)。结论 LL-37检测可作为慢性乙型肝炎患者临床判断病情和预后的一个标志物。 Objective To analyze serocym LL-37 levels in hepatitis B virus-infected subjects,and to explore the correlation with plasma LL-37 levels and liver damage in HBV-infected subjects.Methods Plasma samples were obtained from 90 hepatitis B virus-infected subjects,these subjects were divided three groups as hepatitis B virus patients with mild,moderate and severe chronic B hepatitis.Plasma LL-37 levels were determined using enzyme-linked immunosorbent assay.Results The mean plasma LL-37 concentrations in HBV mild,moderate and severe chronic B virus were lower than matched healthy controls(P0.01).Plasma LL-37 levels decreased with liver damage(P0.01).They were 38.93,33.11,12.87 ng/mL.Conclusion Plasma LL-37 levels provides a useful marker of define disease progression of HBV infection.The change of plasma LL-37 level in patients with chronic hepatitis B can assist diagnosis and predicting prognosis.
出处 《国际检验医学杂志》 CAS 2012年第1期27-28,共2页 International Journal of Laboratory Medicine
关键词 肝炎病毒 乙型 肽抗菌药物 LL-37 血浆 hepatitis B virus peptide antibiotic LL-37 plasma
  • 相关文献

参考文献3

二级参考文献7

共引文献8

同被引文献12

  • 1Morisson P, Neves DD. Evaluation of adenosine deaminase in thediagnosis of pleural tuberculosis: a Brazilian meta-analysis[J]. JBras Pneumol,2008,34(4) :217-224.
  • 2Diirr UH, Sudheedra US, Ramamoorthy A. LL-37 , the only hu-man member of the cathelicidin family of antimicrobial peptides[J]. Biochim Biophys Acta,2006,1758(9) : 1408-1425.
  • 3Bucki R,Leszczynska K, Namiot A, et al. Cathelicidin LL-37 : amultitask antimicrobial peptide [J]. Arch Immunol Ther Exp(Warsz),2010,58(1):15-25.
  • 4Rosenfeld Y,Papo N,Shai Y,et al. Endotoxin (lipopolysaccharide)neutralization by innate immunity host-defense peptides. Peptideproperties and plausible modes of action[J]. J Biol Chem, 2006 ,281(3):1636-1643.
  • 5Nagaoka I, Hirota S, Niyonasaba F, et al. Cathelicidin family ofantibacterial peptides CAP18 and CAP11 inhibit the expression ofTNF-alpha by blocking the binding of LPS to CD14 ( + ) cells[J]. J Immunol,2001,167(6) :3329-3338.
  • 6Mookherjee N,Brown KL, Bowdish DM, et al. Modulation of theTLR-mediated inflammatory response by the endogenous humanhost defense peptide LL-37 [J]. J Immunol, 2006, 176 (4) : 2455-2464.
  • 7Sorci-Thomas MG,Thomas MJ. The effects of altered apolipopro-tein A-I structure on plasma HDL concentration[J]. Trends Card-iovasc Med,2002,12(3) :121-128.
  • 8王娴默,肖林,范文,张家均,董虹,雷选斌.乙型肝炎病毒HBsAg检测假阳性原因分析[J].国际检验医学杂志,2010,31(5):423-424. 被引量:4
  • 9郭翀,张真铭.ELISA法检测HBsAg实验条件的优化[J].国际检验医学杂志,2011,32(6):656-657. 被引量:7
  • 10谢灿茂.重视胸膜疾病的诊治和研究[J].中华结核和呼吸杂志,2001,24(1):6-7. 被引量:58

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部